Gottheimer Urges Gilead to Expand Access to Investigational COVID-19 Treatment for Patients with Severe Symptoms

Mar 28, 2020
Press

Doctors in North Jersey continue vying for access to COVID-19 treatment for patients fighting for their lives — like Bergenfield 34-year-old father of two, Michael Goldsmith

On Saturday, March 28, 2020, U.S. Congressman Josh Gottheimer (NJ-5) released the following statement:

“Gilead Sciences is continuing to deny access of its investigational COVID-19 drug remdesivir to some patients suffering from extreme symptoms of the disease — including some patients in North Jersey, like 34-year-old Bergenfield resident and father of two, Michael Goldsmith, who is currently suffering from extreme COVID-19 complications and fighting for his life.

I continue to be a strong supporter of the life sciences and pharmaceutical work that takes place in my District in North Jersey and all around the country. Now is the time for companies to expand their efforts and strengthen their commitment to effectively treating more patients, helping develop the cures we need, and provide access to those who need it most. Lives throughout New Jersey and across America are depending on it.”

###

Recent Posts


May 20, 2024
Press

RELEASE: In Cherry Hill, Gottheimer Continues His Advocacy Against Deceptive, Anti-Choice Crisis Pregnancy Centers in NJ

More than 50 misleading Crisis Pregnancy Centers across NJ Stopping dangerous mis- and disinformation about reproductive healthcare Above: Gottheimer in front of an anti-choice clinic posing as a legitimate healthcare provider. CHERRY HILL, NJ — Today, Monday, May 20, 2024, U.S. Congressman Josh Gottheimer (NJ-5) sounded the alarm on anti-choice Crisis Pregnancy Centers (CPCs) posing […]



May 16, 2024
Press

RELEASE: Gottheimer, Hill Lead Bipartisan Letter of 51 Members

Urges Treasury and State Departments to Designate and Sanction UNRWA Employees Involved in the October 7 Terrorist Attacks WASHINGTON, DC — Today, Thursday, May 16, 2024, U.S. Representatives Josh Gottheimer (NJ-5) and French Hill (AR-2) led a lettersigned by a group of 51 bipartisan Members of Congress to Treasury and State Departments to take action against the […]



May 16, 2024
Press

RELEASE: Gottheimer Introduces Bipartisan Bill to Support Victims of Terrorism

WASHINGTON, DC — Today, Thursday, May 16, 2024, U.S. Representatives Josh Gottheimer (NJ-5), Mike Lawler (NY-17), Dan Goldman (NY-10), and Nicole Malliotakis (NY-11) introduced the bipartisan, bicameral American Victims of Terror Compensation Act, which provides funding for the United States Victims of State Sponsored Terrorism Fund, or USVSST Fund. Senators Richard Blumenthal (D-CT) and John Cornyn (R-TX) […]